EP 3056187 B1 20180822 - SINGLE-DOSE PHARMACEUTICAL PREPARATION OF THYROID HORMONES T3 AND/OR T4
Title (en)
SINGLE-DOSE PHARMACEUTICAL PREPARATION OF THYROID HORMONES T3 AND/OR T4
Title (de)
PHARMAZEUTISCHES EINZELDOSIS-PRÄPARAT AUS DEN SCHILDDRÜSENHORMONEN T3 UND/ODER T4
Title (fr)
PRÉPARATION PHARMACEUTIQUE À DOSE UNIQUE D'HORMONES THYROÏDIENNES T3 ET/OU T4
Publication
Application
Priority
- IT MI20112066 A 20111114
- EP 12798182 A 20121113
- EP 2012072482 W 20121113
Abstract (en)
[origin: WO2013072304A1] The present invention relates to a single-dose formulation for oral use of the thyroid hormones triiodothyronine or liothyronine (T3) and tetraiodothyronine or thyroxine (T4) in water-alcohol solution, which is physically and chemically stable, protected against accidental or microbiological contamination, in a container for pharmaceutical use which is squeezable and impermeable to the evaporation of the volatile substances it contains, and the corresponding means for implementing it.
IPC 8 full level
A61J 7/00 (2006.01); A61J 1/00 (2006.01); A61K 9/08 (2006.01); A61K 31/198 (2006.01); A61K 47/10 (2017.01)
CPC (source: CN EP RU US)
A61J 1/00 (2013.01 - US); A61J 3/07 (2013.01 - RU); A61K 9/0095 (2013.01 - CN EP US); A61K 9/48 (2013.01 - RU); A61K 31/197 (2013.01 - US); A61K 31/198 (2013.01 - CN EP US); A61K 38/19 (2013.01 - RU); A61K 47/10 (2013.01 - CN EP US); A61P 5/14 (2017.12 - EP)
C-Set (source: CN EP US)
Citation (opposition)
Opponent : Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.
- WO 2010086030 A1 20100805 - ALTERGON SA [CH], et al
- EP 1291021 A2 20030312 - ALTERGON SA [CH]
- US 3128920 A 19640414
- US 2006183804 A1 20060817 - BRINKMAN KYLE R [US], et al
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2013072304 A1 20130523; CA 2853880 A1 20130523; CA 2853880 C 20191210; CN 103987358 A 20140813; CN 103987358 B 20170426; CN 107049929 A 20170818; CN 107049929 B 20200804; DK 2790638 T3 20170403; DK 3056187 T3 20181210; DK 3056187 T4 20230925; EP 2790638 A1 20141022; EP 2790638 B1 20170104; EP 3056187 A1 20160817; EP 3056187 A9 20161123; EP 3056187 B1 20180822; EP 3056187 B2 20230830; ES 2621009 T3 20170630; ES 2698521 T3 20190205; ES 2698521 T5 20240122; FI 3056187 T4 20230922; HK 1200692 A1 20150814; HU E033305 T2 20171128; IT MI20112066 A1 20130515; PL 2790638 T3 20170731; PL 3056187 T3 20190228; PL 3056187 T5 20231204; PT 2790638 T 20170419; PT 3056187 T 20181128; RU 2014119151 A 20151227; RU 2018140275 A 20190118; RU 2018140275 A3 20220323; RU 2688430 C2 20190521; US 2014179785 A1 20140626
DOCDB simple family (application)
EP 2012072482 W 20121113; CA 2853880 A 20121113; CN 201280055960 A 20121113; CN 201710217112 A 20121113; DK 12798182 T 20121113; DK 16154717 T 20121113; EP 12798182 A 20121113; EP 16154717 A 20121113; ES 12798182 T 20121113; ES 16154717 T 20121113; FI 16154717 T 20121113; HK 15101283 A 20150205; HU E12798182 A 20121113; IT MI20112066 A 20111114; PL 12798182 T 20121113; PL 16154717 T 20121113; PT 12798182 T 20121113; PT 16154717 T 20121113; RU 2014119151 A 20121113; RU 2018140275 A 20121113; US 201213814770 A 20121113